We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.7B
AUM Growth
-$1.68B
(-7.8%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-7.93%
Top 10 Holdings %
Top 10 Hldgs %
29.74%
Holding
577
New
77
Increased
189
Reduced
196
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$164M |
| 2 |
Centene
CNC
|
+$162M |
| 3 |
Eli Lilly
LLY
|
+$143M |
| 4 |
Netflix
NFLX
|
+$139M |
| 5 |
Amazon
AMZN
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$177M |
| 2 |
Intuit
INTU
|
+$176M |
| 3 |
Applied Materials
AMAT
|
+$166M |
| 4 |
Advanced Micro Devices
AMD
|
+$115M |
| 5 |
CrowdStrike
CRWD
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.33% |
| 2 | Healthcare | 24.22% |
| 3 | Consumer Discretionary | 14.38% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOAH
401
Noah Holdings
NOAH
$583M
| $432K | ﹤0.01% |
32,688
-4,000
| -11% | -$68K |
|
402
Vinci Compass Investments Ltd
VINP
$649M
| $416K | ﹤0.01% |
40,470
| – | – |
|
|
VTYX
403
DELISTED
Ventyx Biosciences
VTYX
| $415K | ﹤0.01% |
+11,879
| New | +$263K |
|
|
AKRO
404
DELISTED
Akero Therapeutics
AKRO
| $408K | ﹤0.01% |
+11,981
| New | +$183K |
|
|
NUVL
405
DELISTED
Nuvalent
NUVL
| $401K | ﹤0.01% |
20,651
+14,402
| +230% | +$241K |
|
406
SOPHiA GENETICS
SOPH
$483M
| $401K | ﹤0.01% |
152,593
+35
| +0% | +$123 |
|
407
Rapid Micro Biosystems
RPID
$105M
| $400K | ﹤0.01% |
123,830
-1
| -0% | -$4 |
|
|
RNLX
408
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $394K | ﹤0.01% |
307,642
+61
| +0% | +$133 |
|
409
Immunocore
IMCR
$1.72B
| $374K | ﹤0.01% |
+7,977
| New | +$380K |
|
410
Amylyx Pharmaceuticals
AMLX
$2.31B
| $362K | ﹤0.01% |
12,842
+7,713
| +150% | +$192K |
|
411
Cartesian Therapeutics
RNAC
$227M
| $361K | ﹤0.01% |
7,334
-40
| -0.5% | -$2.2K |
|
412
Rockwell Automation
ROK
$52.4B
| $345K | ﹤0.01% |
1,603
| – | – |
|
413
Syndax Pharmaceuticals
SNDX
$1.73B
| $327K | ﹤0.01% |
+13,618
| New | +$306K |
|
414
BioAtla
BCAB
$5.61M
| $317K | ﹤0.01% |
+823
| New | +$269K |
|
415
Tenet Healthcare
THC
$21.8B
| $316K | ﹤0.01% |
6,130
+2,145
| +54% | +$127K |
|
416
Okta
OKTA
$24.4B
| $313K | ﹤0.01% |
5,497
+230
| +4% | +$19.8K |
|
|
KDNY
417
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $313K | ﹤0.01% |
+15,925
| New | +$319K |
|
418
CRISPR Therapeutics
CRSP
$4.77B
| $299K | ﹤0.01% |
+4,573
| New | +$331K |
|
419
Pool Corp
POOL
$6.95B
| $297K | ﹤0.01% |
932
-31,688
| -97% | -$11.3M |
|
|
RPTX
420
DELISTED
Repare Therapeutics
RPTX
| $295K | ﹤0.01% |
24,311
+1,539
| +7% | +$19.8K |
|
421
Allegion
ALLE
$13.4B
| $294K | ﹤0.01% |
3,277
-400
| -11% | -$39.6K |
|
422
Entrada Therapeutics
TRDA
$263M
| $283K | ﹤0.01% |
+17,955
| New | +$228K |
|
423
Levi Strauss
LEVI
$9.45B
| $266K | ﹤0.01% |
18,405
| – | – |
|
424
Biomea Fusion
BMEA
$88.2M
| $256K | ﹤0.01% |
+26,204
| New | +$301K |
|
425
Milestone Pharmaceuticals
MIST
$143M
| $245K | ﹤0.01% |
+26,672
| New | +$202K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2022 Portfolio in Review
As of Q3 2022, Fred Alger Management held 577 positions worth $19.7B, down 7.8% from $21.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fred Alger Management withdrew a net $1.56B in Q3 2022, closing 58 positions and reducing 196 holdings. Its most notable exit was NXP Semiconductors, an estimated $64.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Marvell Technology worth $142M.
- Fred Alger Management's largest Q3 2022 buy was Marvell Technology: 3,318,860 shares worth $142M.
- Fred Alger Management added most to Centene in Q3 2022, an estimated $162M increase.
- Fred Alger Management's biggest Q3 2022 reduction was Visa, cutting an estimated $177M.
- Fred Alger Management fully exited NXP Semiconductors in Q3 2022, selling an estimated $64.7M.
- Fred Alger Management's ten largest holdings make up 30% of its $19.7B portfolio in Q3 2022.
- Fred Alger Management opened 77 new positions and closed 58 in Q3 2022.
- Fred Alger Management's portfolio value fell 7.8% quarter-over-quarter to $19.7B.
Based on Fred Alger Management's 13F filing for Q3 2022, filed 15 Nov 2022.